Lotus Award
Supports bold, collaborative research for transformative breakthroughs in ovarian cancer understanding, diagnosis, prevention, or treatment through innovative, high-risk projects.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): February 2027: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years; includes up to 10% indirect costs)
Summary: Supports bold, collaborative research to advance transformative solutions for ovarian cancer.
Key Information: Forecasted opportunity—dates and details may shift; nomination by an Advisory Board member or Prize winner required.
Description
The Pershing Square Lotus Award aims to catalyze innovative, high-risk, high-reward research in ovarian cancer, the deadliest gynecologic cancer and one of the most underfunded areas in women’s health. The award seeks to bring new perspectives and foster collaboration by supporting both established ovarian cancer researchers and investigators from other cancer disciplines. Projects should focus on transformative solutions with the potential for significant impact on the understanding, diagnosis, prevention, or treatment of ovarian cancer—especially those that might be too risky for traditional funding sources.
